Floating density of hepatitis C virus particles and response to interferon treatment

Journal of Medical Virology

Volumn 55, Issue 1, 1998, Pages 12-17

  Sakai, Akito ^a   Kaneko, Shuichi ^a   Matsushita, Eiki ^a   Kobayashi, Kenichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Hypervariable region; Quasispecies; Single strand conformation polymorphism

Indexed keywords

ALPHA2A INTERFERON;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; VIRUS DETECTION; VIRUS PARTICLE;

ADULT; AGED; ANTIVIRAL AGENTS; CENTRIFUGATION, DENSITY GRADIENT; FEMALE; GENETIC HETEROGENEITY; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; VIRION;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0031859689     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199805)55:1<12::AID-JMV3>3.0.CO;2-R     Document Type: Article

References (26)

1. Adrian M, Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Sreven MB, Hoofnagle JH (1989): Recombinant interferon alpha therapy for chronic hepatitis C: a randomized double-blind placebo-controlled trial. New England Journal of Medicine 321:1506-1510.
2. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, VanThiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, and the Hepatitis Interventional Therapy Group (1989): Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized, controlled trial. New England Journal of Medicine 321:1501-1506.
3. Enomoto N, Kurosaki M, Tanaka Y, Marumo F, Sato C (1994): Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. Journal of General Virology 75:1361-1369.
4. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C (1995): Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b: sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. Journal of Clinical Investigation 96:224-230.
5. Feinstone SM, Alter HJ, Dienes HP, Shimizu Y, Popper H, Blackmore D, Sly D, London WT, Purcell RH (1981): Non-A, non-B hepatitis in chimpanzees and marmosets. Journal of Infectious Disease 144: 588-598.
6. Havel RJ, Howard AE, Bragton JH (1955): The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. Journal of Clinical Investigation 34:1345-1353.
7. Hayashi Y, Kaneko S, Jomori T, Kobara Y, Suzuki E, Tasaka F, Murakami S, Kobayashi K, Mitani T (1994): A simple single-tube procedure of PCR assay for the detection of hepatitis C virus RNA. Research Virology 145:123-128.
8. Hijikata M, Shimizu Y.K, Kato H, Iwamoto A, Shih JW, Alter HJ, Purcell RH, Yoshikura H (1993): Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. Journal of Virology 67:1953-1958.
9. International Group (1977): Acute and chronic hepatitis revisited. Lancet ii:915-919.
10. Kanto T, Hayashi N, Takehara T, Hagiwara H, Mita E, Naito M, Kasahara A, Fusamoto H, Kamada T (1994): Buoyant density of hepatitis C virus recovered from infected hosts: two different features in sucrose equilibrium density-gradient centrifugation related to degree of liver inflammation. Hepatology 19:296-302.
11. Kanto T, Hayashi N, Takehara T, Hagiwara H, Mita E, Naito M, Kasahara A, Fusamoto H, Kamada T (1995a): Density analysis of hepatitis C virus particle population in the circulation of infected hosts: implications for virus neutralization or persistence. Journal of Hepatology 22:440-448.
12. Kanto T, Hayashi N, Takehara T, Hagiwara H, Mita E, Oshita M, Kasahara A, Fusamoto H, Kamada T (1995b): Serial density analysis of hepatitis C virus particle populations in chronic hepatitis C patients treated with interferon-α. Journal of Medical Virology 46:230-237.
13. Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata M, Ohkoshi S, Shimotohno K (1993): Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. Journal of Virology 67:3923-3930.
14. Koizumi K, Enomoto N, Kurosaki M, Murakami T, Izumi N, Marumo F, Sato C (1995): Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 22:30-35.
15. Moribe T, Hayashi N, Kanazawa Y, Mita E, Fusamoto H, Negi M, Kaneshige T, Igimi H, Kamada T, Uchida K (1995): Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy. Gastroenterology 108:789-795.
16. Nagasaka A, Hige S, Tsunematsu I, Yoshida J, Sasaki Y, Matsushima T, Asaka M (1996): Changes in hepatitis C virus quasispecies and density populations in patients before and after interferon therapy. Journal of Medical Virology 50:214-220.
17. Nakamoto Y, Kaneko S, Ohono H, Honda M, Unoura M, Murakami S, Kobayashi K (1996): B-cell epitopes in hypervariable region 1 of hepatitis C virus obtained from patients with chronic persistent hepatitis. Journal of Medical Virology 50:35-41.
18. Orita M, Suzuki Y, Sekiya T, Hayashi K (1989): Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874-879.
19. Rumi M, Del Ninno E, Parravicini ML, Romeo R, Soffredini R, Donato MF, Wilber J, Russo A, Colombo M (1996): A prospective, randomized trial comparing lymphoblastoid to recombinant interferon alpha 2a as therapy for chronic hepatitis C. Hepatology 24:1366-1370.
20. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H (1994): Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. Journal of Virology 68:1494-1500.
21. Simmonds P (1995): Variability of hepatitis C virus. Hepatology 21: 570-583.
22. Thomssen R, Bonk S, Propfe C, Heermann KH, Kochel HG, Uy A (1992): Association of hepatitis C virus in human sera with beta-lipoprotein. Medical Microbiology and Immunology 181:293-300.
23. Thomssen R, Bonk S, Thiele A (1993): Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Medical Microbiology and Immunology 182:329-334.
24. Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto M, Iwasaki S, Kobayashi M, Hiromitsu K (1994): Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 19:1088-1094.
25. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, Brunetto M, Barr PJ, Miyamura T, McHutchinson J, Houghton M (1992): Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections. Proceedings of the National Academy of Sciences of the USA 89:3468-3472.
26. Zibert A, Schreier E, Roggendorf M (1995): Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 208:653-661.